BNKK
Price
$3.75
Change
+$3.36 (+861.54%)
Updated
Feb 3, 04:59 PM (EDT)
Capitalization
21.3M
22 days until earnings call
Intraday BUY SELL Signals
PBH
Price
$64.50
Change
+$1.71 (+2.72%)
Updated
Feb 3, 04:59 PM (EDT)
Capitalization
3.15B
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNKK vs PBH

Header iconBNKK vs PBH Comparison
Open Charts BNKK vs PBHBanner chart's image
Bonk
Price$3.75
Change+$3.36 (+861.54%)
Volume$5.23K
Capitalization21.3M
Prestige Consumer Healthcare
Price$64.50
Change+$1.71 (+2.72%)
Volume$4.58K
Capitalization3.15B
BNKK vs PBH Comparison Chart in %
BNKK
Daily Signal:
Gain/Loss:
PBH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BNKK vs. PBH commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNKK is a Hold and PBH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BNKK: $4.01 vs. PBH: $65.44)
Brand notoriety: BNKK and PBH are both not notable
BNKK represents the Investment Managers, while PBH is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNKK: 3% vs. PBH: 91%
Market capitalization -- BNKK: $21.3M vs. PBH: $3.15B
BNKK [@Investment Managers] is valued at $21.3M. PBH’s [@Pharmaceuticals: Generic] market capitalization is $3.15B. The market cap for tickers in the [@Investment Managers] industry ranges from $173.66B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.68B to $0. The average market capitalization across the [@Investment Managers] industry is $7.45B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNKK’s FA Score shows that 0 FA rating(s) are green whilePBH’s FA Score has 0 green FA rating(s).

  • BNKK’s FA Score: 0 green, 5 red.
  • PBH’s FA Score: 0 green, 5 red.
According to our system of comparison, PBH is a better buy in the long-term than BNKK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNKK’s TA Score shows that 6 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).

  • BNKK’s TA Score: 6 bullish, 4 bearish.
  • PBH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BNKK is a better buy in the short-term than PBH.

Price Growth

BNKK (@Investment Managers) experienced а -16.80% price change this week, while PBH (@Pharmaceuticals: Generic) price change was -0.34% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -2.00%. For the same industry, the average monthly price growth was +6.61%, and the average quarterly price growth was +10.32%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +19.34%. For the same industry, the average monthly price growth was +0.79%, and the average quarterly price growth was +16.45%.

Reported Earning Dates

BNKK is expected to report earnings on Feb 25, 2026.

PBH is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Investment Managers (-2.00% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Pharmaceuticals: Generic (+19.34% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.15B) has a higher market cap than BNKK($21.3M). BNKK YTD gains are higher at: 55.426 vs. PBH (6.079). PBH has higher annual earnings (EBITDA): 357M vs. BNKK (-37.41M). PBH has more cash in the bank: 119M vs. BNKK (9.12M). BNKK has less debt than PBH: BNKK (382K) vs PBH (1.04B). PBH has higher revenues than BNKK: PBH (1.11B) vs BNKK (2.29M).
BNKKPBHBNKK / PBH
Capitalization21.3M3.15B1%
EBITDA-37.41M357M-10%
Gain YTD55.4266.079912%
P/E RatioN/A16.20-
Revenue2.29M1.11B0%
Total Cash9.12M119M8%
Total Debt382K1.04B0%
FUNDAMENTALS RATINGS
PBH: Fundamental Ratings
PBH
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
66
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNKKPBH
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 2 days ago
55%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 7 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
BNKK
Daily Signal:
Gain/Loss:
PBH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JUNS0.590.06
+11.78%
Jupiter Neurosciences Inc
CRSP51.311.35
+2.70%
CRISPR Therapeutics AG
RACE336.333.16
+0.95%
Ferrari NV
CDNA20.42-0.13
-0.63%
CareDx
MASS6.19-0.12
-1.90%
908 Devices

BNKK and

Correlation & Price change

A.I.dvisor tells us that BNKK and PBH have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNKK and PBH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNKK
1D Price
Change %
BNKK100%
+4.16%
PBH - BNKK
23%
Poorly correlated
+1.50%
CPIX - BNKK
21%
Poorly correlated
+2.93%
SNDL - BNKK
21%
Poorly correlated
-0.65%
DVAX - BNKK
21%
Poorly correlated
+0.03%
TLRY - BNKK
21%
Poorly correlated
-0.27%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+1.50%
PAHC - PBH
38%
Loosely correlated
+4.38%
IRWD - PBH
32%
Poorly correlated
+1.02%
LFCR - PBH
30%
Poorly correlated
-1.96%
ELAN - PBH
29%
Poorly correlated
+2.78%
AMRX - PBH
29%
Poorly correlated
+3.73%
More